ARCHIVES

IARC Says Evidence Supports Mammography Screening For 50-69, Limited Evidence For 40-49

This article is from The Cancer Letter archive.

Vol. 28 No. 12 | March 22, 2002

Download PDF Visit The Full Archive

Related Articles

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

In Brief: NCAB To Meet Jan. 15-17; UCLA To Compete For Clinical Neutron Therapy Contract

January 5, 1979

NCI Funded Over 4,500 Grants Last Year, Half Its $3B Budget.

January 19, 2001

CCOPs At Six Months: Sme Exceeding Patient Goals, Most Are Meeting Schedules

March 30, 1984

Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials

December 2, 1977

New Drugs Improve Outlook For Bone Marrow Cancer

March 31, 2006